Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
8,21 USD | -3,41 % | -7,96 % | +4,19 % |
27/03 | Les actions d'Outlook Therapeutics augmentent après le relèvement de la note de BTIG | MT |
27/03 | OUTLOOK THERAPEUTICS, INC. : BTIG réajuste son opinion à la hausse | ZM |
Métier
Nombre d'employés: 24
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
C. Trenary
CEO | Chief Executive Officer | 66 | 07/07/21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15/09/15 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 19/01/23 |
Terry Dagnon
COO | Chief Operating Officer | 62 | 01/11/18 |
Alicia Tozier
SAM | Sales & Marketing | - | 02/03/22 |
Joel Prieve
PRN | Corporate Officer/Principal | - | 08/02/22 |
Jeff Evanson
PRN | Corporate Officer/Principal | 55 | 01/11/18 |
Jennifer Kissner
PRN | Corporate Officer/Principal | - | 26/04/19 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Randy Thurman
CHM | Chairman | 74 | 13/04/18 |
Kurt Hilzinger
BRD | Director/Board Member | 63 | 11/12/15 |
C. Trenary
CEO | Chief Executive Officer | 66 | 07/07/21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15/09/15 |
Yazan Haddadin
BRD | Director/Board Member | 48 | 31/10/17 |
Julian Gangolli
BRD | Director/Board Member | 66 | 20/04/20 |
Gerd Auffarth
BRD | Director/Board Member | 59 | 20/04/20 |
Julia Haller
BRD | Director/Board Member | 69 | 11/08/22 |
Director/Board Member | 39 | 11/09/17 | |
Andong Huang
BRD | Director/Board Member | 27 | 19/06/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 22 298 542 | 13 636 212 ( 61,15 %) | 0 | 61,15 % |
Coordonnées société
Outlook Therapeutics, Inc.
485 Route 1 South Building F, Suite 320
08852, Iselin
+609 619 3990
http://www.outlooktherapeutics.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+4,19 % | 198 M | |
+21,74 % | 46,81 Md | |
-0,97 % | 41,37 Md | |
+47,07 % | 41,29 Md | |
-3,52 % | 28,87 Md | |
+11,12 % | 26,06 Md | |
-19,37 % | 19,13 Md | |
+31,18 % | 12,39 Md | |
-0,04 % | 12,08 Md | |
+0,39 % | 11,96 Md |
- Bourse
- Actions
- Action OTLK
- Société Outlook Therapeutics, Inc.